✦ LIBER ✦

Trastuzumab plus Docetaxel in HER2/neu–Positive Non–Small-Cell Lung Cancer: A California Cancer Consortium Screening and Phase II Trial

✍ Scribed by Primo N. Lara Jr; Luko Laptalo; Jeff Longmate; Derick H.M. Lau; Regina Gandour-Edwards; Paul H. Gumerlock; James H. Doroshow; David R. Gandara

Book ID: 119935495
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 151 KB
Volume: 5
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2004.n.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab plus docetaxel in HER-2/neu-

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma : Final results from the California Cancer Consortium screening and Phase II trial

✍ Primo N. Lara Jr.; Karen Giselle Chee; Jeff Longmate; Christopher Ruel; Frederic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Overexpression of the HER‐2/__neu__ oncoprotein has been reported to occur in ≤ 60% of patients with prostate carcinoma and to correlate with shortened survival. Trastuzumab is a humanized monoclonal antibody to the HER‐2 receptor and has activity against HER‐2–positive b

Randomized Phase II Trial of Concurrent

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

✍ Primo N. Lara Jr; Jeff Longmate; Karen Reckamp; Barbara Gitlitz; Athanassios Arg 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

Randomized phase II trial comparing tras

Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Krug, L.M; Miller, V.A; Crapanzano, J.P; Zakowski, M.F; Ng, K.K; Heelan, R.T; Ro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Activity of high-dose toremifene plus ci

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial

✍ Primo N. Lara; David R. Gandara; Jeff Longmate; Paul H. Gumerlock; Derick H. Lau 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 103 KB

Salvage gemcitabine (GEM) in platinum-tr

Salvage gemcitabine (GEM) in platinum-treated non-small cell lung cancer (NSCLC): A phase II California cancer consortium trial

✍ Lara, P; Law, L; Reddy, G.R; Edelman, M.J; Doroshow, J.H; Lau, D.H.M; Lenz, H.J; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Phase I/II trial of gemcitabine plus doc

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB